Advertisement

The Team and the Assessment

  • Cosimo Bruni
  • Tiziana Pucci
  • Laura Rasero
  • Christopher P. Denton
Chapter

Abstract

Digital ulcers are known as a heavy clinical burden in patients with systemic sclerosis, leading to important limitations to everyday life. Keeping in mind the partial agreement on digital ulcers definition, the assessment of skin lesions is currently focussed on count and the appearance of new ulcers. Conversely, different tools are available to monitor the effect of digital ulcers on patient’s subjective perception of quality of life, with pain, general disability and hand-centred disability being the domains generally evaluated in clinical practice (with scales and questionnaires such as the Visual Analogue Scale [VAS], the Health Assessment Questionnaire Disability Index [HAQ-DI] and the recently proposed Hand Disability in Systemic Sclerosis Digital Ulcer [HDISS-DU]). On the other hand, no objective outcome measure is now available to follow up digital ulcers evolution in clinical practice, and this represents an unmet need to be solved, in order to have a validated tool to be used also in randomized clinical trials.

Keywords

Digital ulcers Definition Assessment Outcome measure Scales Questionnaires Healing Disability Hand function Pain Quality of life 

References

  1. 1.
    Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol. 1992;19(9):1407–14.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P, et al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2011;70(1):32–8.CrossRefGoogle Scholar
  3. 3.
    Malnutrition Universal Screening Tool BAPEN, registered no: 1023927. First published May 2004 by the Malnutrition Advisory Group, a Standing Committee of BAPEN. Reviewed and reprinted March 2008 and September 2010. British Dietetic Association, the Royal College of Nursing and the Registered Nursing Home Association. Available on: www.bapen.org.uk.
  4. 4.
    Steen V, Denton CP, Pope JE, Matucci-Cerinic M. Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford). 2009;48(Suppl 3):iii19–24.  https://doi.org/10.1093/rheumatology/kep105. ReviewCrossRefGoogle Scholar
  5. 5.
    Pope J. Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS). Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S98–111.CrossRefGoogle Scholar
  6. 6.
    Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum. 2002;46(9):2410–20.CrossRefGoogle Scholar
  7. 7.
    Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum. 2004;50(12):3985–93.CrossRefGoogle Scholar
  8. 8.
    Zelenietz C, Pope J. Differences in disability as measured by the Health Assessment Questionnaire between patients with and without digital ulcers in systemic sclerosis: a post hoc analysis of pooled data from two randomized controlled trials in digital ulcers using bosentan. Ann Rheum Dis. 2010;69(11):2055–6.CrossRefGoogle Scholar
  9. 9.
    Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum. 1997;40(11):1984–91.CrossRefGoogle Scholar
  10. 10.
    Smyth AE, MacGregor AJ, Mukerjee D, Brough GM, Black CM, Denton CP. A cross- sectional comparison of three self-reported functional indices in scleroderma. Rheumatology. 2003;42:732–8.CrossRefGoogle Scholar
  11. 11.
    Serednicka K, Smyth AE, Black CM, Denton CP. Using a self-reported functional score to assess disease progression in systemic sclerosis. Rheumatology (Oxford). 2007;46(7):1107–10.CrossRefGoogle Scholar
  12. 12.
    Duruöz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, Dougados M, et al. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol. 1996;23(7):1167–72.PubMedGoogle Scholar
  13. 13.
    Brower LM, Poole JL. Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum. 2004;51(5):805–9. Erratum in: Arthritis Rheum. 2005;53(2):303CrossRefGoogle Scholar
  14. 14.
    Mouthon L, Mestre-Stanislas C, Bérezné A, Rannou F, Guilpain P, Revel M, et al. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis. 2010;69(1):214–7.CrossRefGoogle Scholar
  15. 15.
    Impens AJ, Chung KC, Buck MH, Schiopu E, Kotsis S, Burns P, et al. Influences of clinical features of systemic sclerosis (Ssc) on the Michigan Hand Questionnaire (MHQ). [abstract]. Arthritis Rheum. 2006;54(Suppl,9):S483.Google Scholar
  16. 16.
    Khanna D, Poiraudeau S, Gelhom H, Hunsche E, Papadakis K, Perchenet L, et al. Development and content validity of the Hand Disability in systemic sclerosis Digital ulcers (HDISS-SU) scale. [abstract]. Arthritis Rheum. 2011;63 Suppl 10:1863.Google Scholar
  17. 17.
    Ingegnoli F, Boracchi P, Ambrogi F, Meroni PL. Comparative analysis of different specific indices of hand impairment in systemic sclerosis. J Rheumatol. 2010;37(10):2192–3.CrossRefGoogle Scholar
  18. 18.
    Matucci-Cerinic M, Seibold JR. Digital ulcers and outcomes assessment in scleroderma. Rheumatology (Oxford). 2008;47 Suppl 5:v46–7.CrossRefGoogle Scholar
  19. 19.
    Ahrens HC, Siegert E, Tomsitz D, Mattat K, March C, Worm M, et al. Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis. Clin Exp Rheumatol. 2016;34 Suppl 100(5):142–7.PubMedGoogle Scholar
  20. 20.
    Bruni C, Ngcozana T, Braschi F, Piemonte G, Benelli L, Guiducci S, et al. The Ducas: proposal for a digital ulcer assessment score in scleroderma. [abtract]. Arthritis Rheumatol. 2016;68(suppl 10)Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Cosimo Bruni
    • 1
  • Tiziana Pucci
    • 2
  • Laura Rasero
    • 3
  • Christopher P. Denton
    • 4
  1. 1.Department of Experimental and Clinical Medicine, Division of RheumatologyUniversity of FlorenceFlorenceItaly
  2. 2.Department of Geriatric Medicine, Division of RheumatologyAOUCFlorenceItaly
  3. 3.Department of Health SciencesUniversity of Florence – Careggi of HospitalFlorenceItaly
  4. 4.Division of MedicineUniversity College London, Centre for Rheumatology, Royal Free HospitalLondonUK

Personalised recommendations